
Tag: pharmaceuticals


NICE recommends Epidyolex for treatment of tuberous sclerosis complex

Portuguese Meducal Cannabis Company VF1883 Pharmaceuticals Declared Insolvent

Two More Studies Show Patients Are Replacing Prescription Painkillers With Marijuana

North America Legal Cannabis Market Report 2022: Featuring 22nd Century, Medical Marijuana Inc, Arena Pharmaceuticals & More – ResearchAndMarkets.com

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility

Virpax Pharmaceuticals to Utilize Dr. Neil K. Singla to Assist in Development of Probudur™

Psychedelics Market Expected To Hit Approx. $12 Billion by 2029

Celadon Pharmaceuticals Shares Rise After UK Quality Standard Registration

USA | Even without proof, CBD is finding a niche as a cure-all

JAMAICA | Cannabis class at UWI Jamaica campus today

Virpax Pharmaceuticals Engages Destum Partners to Direct Strategic Global Partnering Efforts

Pain Patients Are Switching To Medical Marijuana Instead Of Opioids, American Medical Association Study Shows

Utah Group Aims To Legalize Shrooms in the State

Lawsuit: Generic drugmakers infringed on Epidiolex cannabis drug patents

Anebulo Pharmaceuticals Announces Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid Intoxication

Pharma Company Behind FDA-Approved CBD Drug Sues A Dozen Competitors Over Alleged Patent Infringement

Virpax Pharmaceuticals Engages Dr. Kenneth W. Sommerville and Dr. Lawrence Fried to Assist in Development of NobrXiol™ (formerly VRP324)

Google Updates Policy To Allow Hemp, CBD Products with Certification

This high-tech, grow-it-yourself medical cannabis kit is as easy as using an app

Google Ends Ban On Advertising Certain Hemp And CBD Products In Parts Of U.S.

Singapore: ‘Scientific evidence’ to guide cannabis law

Cannabis An Alternative Treatment to Pharmaceuticals .Check out this video

Colorado to allow CBD prescriptions.

A Marijuana Market Most Investors Aren’t Thinking About — The Motley Fool

Virpax Pharmaceuticals Reports on FDA Pre-IND Response for NobrXiol™ (formerly VRP324)

A Look At The Cannabis Movement In The UK

Global Industrial Hemp Market Report 2022: Growing Use of Hemp Seed and Hemp Seed Oil in Food Applications Fuels Sector – ResearchAndMarkets.com

Fentanyl Overdose Reversal Drug Stronger Than Narcan Released

ADDING MULTIMEDIA MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022

TerrAscend Appoints Seasoned Finance Professional to Board

Marinus Pharmaceuticals Announces Presentations and Investor Event at American Epilepsy Society 2022 Annual Meeting

Jazz Pharma to present new research findings on Epidyolex

Royal Emerald Pharmaceuticals Partners with BioHarvest Sciences to Supply Disruptive Cannabis Solutions to Companies Conducting FDA-Approved Medical Research

Family left ‘reeling’ after NHS neurologist turns their back on cannabis patient

MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Drug Research

Another Medical Cannabis Clinical Trial Launches in South Africa

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates

Global Cannabis Pharmaceuticals Market (2022 to 2027) – Featuring AbbVie, Amyris, Aurora Cannabis and Botanix Pharmaceuticals Among Others – ResearchAndMarkets.com

Virpax Pharmaceuticals Reports 2022 Third Quarter Results

Longboard Pharmaceuticals to Present at Guggenheim’s Healthcare Talks 4th Annual Immunology and Neurology Day

Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results

Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors

Survey reveals broad spectrum of issues facing UK cannabis patients

Global Medical Marijuana Market Forecast to 2028 – Featuring Aphria, Canopy Growth, CanaQuest Medical and GW Pharmaceuticals Among Others – ResearchAndMarkets.com

Flora Growth to Acquire Pharmaceutical, Medical Cannabis Distributor in Germany

Study To Examine Why Shrooms Evolved with Psychedelic Properties

Washington State Liquor and Cannabis Board Seeks Members for Cannabinoid Science Work Group

New Research Exploring DMT as a Treatment for Stroke

Welsh campaigners to help educate doctors on medical cannabis

Press Release: Biomind Labs and Queen’s University of Belfast Receive Controlled Substances License to Commence the Production of a Novel Transdermal Drug Delivery System

Educated Stoner

Japanese Health Officials Propose Revision of Law To Allow Import, Medical Cannabis

Three Major Australian Medical Cannabis Companies Fined By The TGA “over claims prescriptions could treat conditions such as cancer and epilepsy”

Controlled Release Cannabis Pill Global Market Insights 2022: Analysis and Forecast to 2027 by Manufacturers, Regions, Technology, Application, Product Type – ResearchAndMarkets.com

Medical Marijuana Helps Patients Reduce Use Of Addictive Opioid Painkillers, Study Finds

Anebulo Pharmaceuticals Announces $6.6 Million Private Placement Financing

Anebulo Pharmaceuticals Announces Positive Interim Data for ANEB-001 from Part B of its Phase 2 Clinical Trial for Acute Cannabinoid Intoxication

SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility

Rapid Dose Therapeutics Enters Supplier and Purchase Agreement with a Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products

AR court upholds cannabis ballot measure (Newsletter: September 23, 2022)

Congressman Says Psychedelics Show ‘Real Promise’ As Alternative Therapies At Committee Hearing

Aurora Cannabis has been deleted from the S&P/TSX Composite Index

MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan

Anebulo Pharmaceuticals to Webcast R&D Day on September 26, 2022

Apple Lets Users Search For Marijuana And Pharmaceutical Interactions In Latest iPhone Health Update

Cannabis-based Sativex to be available on NHS in Scotland

Merida Capital Holdings Partners With Azucarera El Viejo for Medical Cannabis Facility in Costa Rica

Cannabis-based Sativex to be available on NHS in Scotland

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Highlights Recent Business Progress

Ramm Pharma buys Polish hemp firm from TGOD for CA$1.2 million

Legal Cannabis Sales Dip Sharply in Colorado

Legal Weed Likely To Cost Drug Companies Billions

Marijuana Moment Report: Pharmaceutical Industry Suffers Billions In Losses After States Legalize Marijuana, New Study Finds

Pharmaceutical Industry Suffers Billions In Losses After States Legalize Marijuana, New Study Finds

MyMD Pharmaceuticals Receives Grant From European Patent Office for Supera-CBD™ Compound

Karma Koala Podcast Episode 92 – Monday 29 August: June McLaughlin, Professor and Program Studies Director at Irvine Valley College, Kim Stuck Allay Consulting, Michael Sassano – Somai Pharmaceuticals & Amy McDougal -Clearesources.

UK: A blueprint for the UK Cannabis Industry

Cannabis induced psychosis: Medical cannabis much safer

Dr. Jeffrey Gudin, Chief Medical Officer of Virpax Pharmaceuticals, to Present Poster at World Congress of World Institute of Pain

DEA Chooses Seventh Cannabis Cultivator License for Research Purposes

Jazz Pharma to trial Epidyolex as treatment for Doose syndrome

Cannabis Testing Services Market by Test Type, Product Type, End-users, and Region – Global Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 – ResearchAndMarkets.com

Virpax Pharmaceuticals Reports 2022 Second Quarter Results and Recent Developments

Dravet Syndrome Treatment Market Report 2022-2029: Stiripentol and Cannabidiol to Contribute to Significant Growth of 11.7% – ResearchAndMarkets.com

A Message From Another Time & Galaxy! GW’s cannabis-derived drug Epidiolex finally launches in the US with an average list price of $32,500

Jazz's (JAZZ) Q2 Earnings Beat, New Drugs Post Robust Sales

Data Showing MyMD Pharmaceuticals’ MYMD-1® May Extend Life and Improve Health Published in the Journal of Gerontology: Biological Sciences

Flora Growth Announces Joint Venture with Colombia’s Largest Indigenous Tribe to Process and Distribute Cannabis Products

Tel Aviv Stock Exchange Eliminates TA-Cannabis Index, 4 August.Yaniv Pagot, head of trading TASE ” It’s Irrelevant”

Could CBD help Justin Beiber with Ramsey Hunt Syndrome?

Flora Growth CEO Meets With Colombian Senator as Bill to Legalize Recreational Cannabis Is Introduced

Cannabis-based drug Sativex fails latest clinical trial

Press Release: COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

The Worldwide Cannabidiol Oil Industry is Projected to Reach $3.7 Billion by 2027 – ResearchAndMarkets.com

GreenLab Packaging Helps to Redefine Cannabis Packaging

MyMD Pharmaceuticals to Collaborate with Bascom Palmer Eye Institute to Study MYMD-1 in Ophthalmic Conditions

Can a new AI-powered app enhance medical cannabis treatment?

Canopy Growth Corporation v. GW Pharma Limited and GW Research Limited, Case No. 6:20-cv-01180 (W.D. Tex.)
